Inspire Medical Systems Inc (INSP) — Capital Reinvestment Ratio

Latest as of June 2026: 0.39x

Inspire Medical Systems Inc (INSP) has a Capital Reinvestment Ratio of 0.39x as of June 2026, meaning it reinvests 0% of its operating cash flow ($23.23 Million) in capital expenditures ($9.16 Million). Check Inspire Medical Systems Inc tangible equity quality to evaluate the tangible quality of the company's equity base.

Capital Reinvestment Ratio

0.39x
Capex / Operating Cash Flow

Operating Cash Flow

$23.23 Million
USD

Capital Expenditures

$9.16 Million
USD

Data as of

Jun 2026
Most recent filing

Inspire Medical Systems Inc Capital Reinvestment Ratio (2022–2025)

This chart tracks Inspire Medical Systems Inc's Capital Reinvestment Ratio across 4 annual periods. For the full cash flow conversion analysis, see cash efficiency ratio of Inspire Medical Systems Inc.

Annual Capital Reinvestment Ratio for Inspire Medical Systems Inc (2022–2025)

Year-by-year Capital Reinvestment Ratio for Inspire Medical Systems Inc from 2022 to 2025. See INSP FCF generation index to measure how efficiently the company converts operating cash flow to free cash.

Year Reinvestment Ratio Operating CF (USD) Capital Expenditures YoY Change
2025 0.33x $116.98 Million $38.50 Million ▲ +9.6%
2024 0.30x $130.25 Million $39.12 Million ▼ -68.7%
2023 0.96x $24.65 Million $23.63 Million ▲ +21.9%
2022 0.79x $11.57 Million $9.10 Million
Capital Reinvestment Ratio = ABS(Capital Expenditures) / Operating Cash Flow